Cargando…

Chromophobe renal cell cancer - review of the literature and potential methods of treating metastatic disease

Chromophobe renal cell carcinoma (ChRCC) is a subtype of renal cell carcinoma (RCC). ChRCC is diagnosed mainly in 6th decade of life. An incidence of ChRCC is similar in both men and woman. Eighty six percent of ChRCCs cases are diagnosed in stage 1 or 2. Prognosis of ChRCC is better than in other t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stec, Rafał, Grala, Bartłomiej, Mączewski, Michał, Bodnar, Lubomir, Szczylik, Cezary
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764641/ https://www.ncbi.nlm.nih.gov/pubmed/19811659 http://dx.doi.org/10.1186/1756-9966-28-134

Ejemplares similares

Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy
por: Smoter, Marta, et al.
Publicado: (2013)

The role of Tau protein in resistance to paclitaxel
por: Smoter, Marta, et al.
Publicado: (2011)

Axitinib in sequential therapy in metastatic renal cell carcinoma
por: Kuchar, Agata, et al.
Publicado: (2016)

Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model
por: Chrom, Pawel, et al.
Publicado: (2018)

Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma
por: Chrom, Pawel, et al.
Publicado: (2018)

Colorectal cancer in the course of familial adenomatous polyposis syndrome (“de novo” pathogenic mutation of APC gene): case report, review of the literature and genetic commentary
por: Stec, Rafał, et al.
Publicado: (2010)

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients
por: Semeniuk-Wojtaś, Aleksandra, et al.
Publicado: (2016)

Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy
por: Kade, Grzegorz, et al.
Publicado: (2012)

Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy
por: Sigorski, Dawid, et al.
Publicado: (2020)

Prognostic Significance of Wnt-1, β-catenin and E-cadherin Expression in Advanced Colorectal Carcinoma
por: Stanczak, Aleksandra, et al.
Publicado: (2011)

Efficacy of temsirolimus in metastatic chromophobe renal cell carcinoma
por: Venugopal, Balaji, et al.
Publicado: (2013)

Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system
por: Rokita, Marta, et al.
Publicado: (2013)

K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy
por: Stec, Rafał, et al.
Publicado: (2012)

Relating Prognosis in Chromophobe Renal Cell Carcinoma to the Chromophobe Tumor Grading System
por: Weinzierl, Elizabeth P, et al.
Publicado: (2014)

Delayed Recurrence of Chromophobe Renal Cell Carcinoma Presenting as Metastatic Duodenal Ulcer
por: Jain, Nikita, et al.
Publicado: (2020)

Chromophobe renal cell carcinoma: A case report and literature review
por: Ballati, Ahmed, et al.
Publicado: (2021)

Seeking new prognostic and predictive factors in patients with metastatic renal cell carcinoma – apoptosis-regulating factors
por: Młot, Beata, et al.
Publicado: (2012)

Seeking new prognostic and predictive factors in patients with metastatic renal cell carcinoma – hypoxia-induced factors
por: Młot, Beata, et al.
Publicado: (2012)

Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer
por: Bodnar, Lubomir, et al.
Publicado: (2014)

Lymphangitic Retroperitoneal Carcinomatosis Occurring From Metastatic Sarcomatoid Chromophobe Renal Cell Carcinoma
por: Alimchandani, Meghna, et al.
Publicado: (2014)

Sunitinib: An Unusual Cause of Pneumothorax in a Patient With Metastatic Chromophobe Renal Cell Carcinoma
por: Bukhari, Nedal, et al.
Publicado: (2020)

Chromophobe Renal Cell Carcinoma of a Renal Allograft
por: Saparbay, Jamilya, et al.
Publicado: (2021)

Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients
por: Synowiec, Agnieszka, et al.
Publicado: (2016)

Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies
por: Klemba, Aleksandra, et al.
Publicado: (2020)

Chromophobe renal cell carcinoma with sarcomatoid changes: case report and review of literature
por: Daga, Dhiraj, et al.
Publicado: (2014)

Sarcomatoid Chromophobe Renal Cell Carcinoma: A Case Report and Review of the Literature
por: Bian, Lihui, et al.
Publicado: (2019)

Sarcomatoid Transrormation of Chromophobe Renal Cell Carcinoma
por: Safavi, Moeinadin, et al.
Publicado: (2016)

Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation
por: Lichtbroun, Benjamin J., et al.
Publicado: (2023)

Intravesical recurrence of chromophobe renal cell carcinoma
por: Kelly, Niall P., et al.
Publicado: (2023)

Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2016)

Incidental Eosinophilic Chromophobe Renal Cell Carcinoma in Renal Allograft
por: Alharbi, Abdullah, et al.
Publicado: (2017)

Proteomic distinction of renal oncocytomas and chromophobe renal cell carcinomas
por: Drendel, Vanessa, et al.
Publicado: (2018)

Compare Fuhrman Nuclear and Chromophobe Tumor Grade on Chromophobe RCC
por: Lin, Tsu-Feng, et al.
Publicado: (2019)

CENPE and LDHA were potential prognostic biomarkers of chromophobe renal cell carcinoma
por: Wu, Hui-feng, et al.
Publicado: (2023)

Chromophobe Renal Cell Carcinoma Presenting as a Cystic Renal Mass: Case Report and Review of the Literature
por: AlGhamdi, Maram H., et al.
Publicado: (2019)

Sarcomatoid Chromophobe Renal Cell Carcinoma with Heterologous Component
por: Bharti, Sushma, et al.
Publicado: (2020)

Clinicopathological and Molecular Characteristics of Macroscopically Yellowish-Colored Chromophobe Renal Cell Carcinoma Compared to Non-Yellowish-Colored Chromophobe Renal Cell Carcinoma
por: Kojima, Fumiyoshi, et al.
Publicado: (2021)

Significant response to nivolumab for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report
por: Noguchi, Go, et al.
Publicado: (2018)

Real-life data of abiraterone acetate and enzalutamide treatment in post-chemotherapy metastatic castration-resistant prostate cancer in Poland
por: Sigorski, Dawid, et al.
Publicado: (2023)

Simultaneous Chromophobe renal cell carcinoma and squamous renal cell carcinoma
por: Fúnez, Rafael, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_lc38epkki6nasqrui2on247830